Ireland
--:--IST
Latest
Clinical Trials in Norway / NCT03114072
Active, not recruiting Not applicable

Blocking Blue Light in Pregnancy, Effects on Melatonin Profile and Sleep

NCT03114072 · tracked via the Priya Life Science Norway tracker
Phase
Not applicable
Started
2017-06-06
Last updated
2024-12-18

Condition(s) studied

Sleep Disturbance

Investigational drug(s) / intervention(s)

Blue-blocking glassesLight grey control glasses

Blue-blocking glasses: Wear the BB-glasses from three hours before bedtime, and if needed to turn on the light, also during the night.

Light grey control glasses: Wear the light grey glasses from three hours before bedtime, and if needed to turn on the light, also during the night.

Study summary

Sleep disturbances are common in pregnancy, and the incidence increases during the third trimester. Light and specially the blue wavelengths of light, is affecting sleep and the circadian rhythm. The main aim of this randomized controlled study is to investigate the effect of Blue-blocking glasses (BB-glasses) used in the evening and night on sleep and mood in pregnant women in the third trimester. The outcome measures assess sleep variables, alertness, melatonin level, sleepiness (subjectively), mood and symptoms of anxiety and depression. In addition we want to measure the pregnancy related sleep problems, alcohol intake, physical activity and perceives stress in the study population, and the association with daily/nightly light exposure.

Eligibility

Sex
FEMALE
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * nulliparous women * expecting one child * being in the third trimester of a normal pregnancy * able to wear an actigraph during daytime and nighttime * able to fill out a questionnaire in Norwegian Exclusion Criteria: * somatic or psychiatric disorders * fever and other health conditions affecting sleep * working at night during the study protocol

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Randi Liset Bergen Norway

More University of Bergen trials in Norway

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03114072 on ClinicalTrials.gov ↗ ← All trials in Norway